Ausgabe 3/2020
Inhalt (26 Artikel)
Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis
Noman Paracha, Adriana Reyes, Véronique Diéras, Ian Krop, Xavier Pivot, Ander Urruticoechea
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer
Thomas L. Gonzalez, Molly Hancock, Siqi Sun, Christina L. Gersch, Jose M. Larios, Wadie David, Jiantao Hu, Daniel F. Hayes, Shaomeng Wang, James M. Rae
Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer
Thomas L. Gonzalez, Molly Hancock, Siqi Sun, Christina L. Gersch, Jose M. Larios, Wadie David, Jiantao Hu, Daniel F. Hayes, Shaomeng Wang, James M. Rae
Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer
Takahito Masuda, Hiroshi Fujimoto, Ryotaro Teranaka, Masayuki Kuroda, Yasuyuki Aoyagi, Takeshi Nagashima, Takafumi Sangai, Mamoru Takada, Ayako Nakagawa, Yoshitaka Kubota, Koutaro Yokote, Masayuki Ohtsuka
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer
Kaitlyn J. Andreano, Suzanne E. Wardell, Jennifer G. Baker, Taylor K. Desautels, Robert Baldi, Christina A. Chao, Kendall A. Heetderks, Yeeun Bae, Rui Xiong, Debra A. Tonetti, Lauren M. Gutgesell, Jiong Zhao, Jessica A. Sorrentino, Delita A. Thompson, John E. Bisi, Jay C. Strum, Gregory R. J. Thatcher, John D. Norris
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy
Denise A. Yardley, Nancy Peacock, Brooke Daniel, Betrand Anz, David C. Molthrop Jr, Sonalee K. Shroff, Robyn Young, Aleksander Jankov, Amy Vander Woude, Mythili Shastry, Johanna Pasek, Laura M. DeBusk, John D. Hainsworth
Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients
Minsung Kim, Hanna Kim, Sei Hyun Ahn, Vafa Tabatabaie, Sung Wook Choi, Guiyun Sohn, Sae Byul Lee, Beom Seok Ko, Il Yong Chung, Jisun Kim, Jong Won Lee, Byung Ho Son, Hee Jeong Kim
The long-term effect of age on cardiovascular disease in patients with breast cancer who received chemotherapy
Ye Won Jeon, Hye Won Bang, Young Jin Suh, GeeHee Kim
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
Irene E. G. van Hellemond, Carolien H. Smorenburg, Petronella G. M. Peer, Astrid C. P. Swinkels, Caroline M. Seynaeve, Maurice J. C. van der Sangen, Judith R. Kroep, Hiltje de Graaf, Aafke H. Honkoop, Frans L. G. Erdkamp, Franchette W. P. J. van den Berkmortel, Wilfred K. de Roos, Sabine C. Linn, Alexander L. T. Imholz, Maaike de Boer, Vivianne C. G. Tjan-Heijnen
Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer
Madoka Iwase, Masashi Ando, Kenjiro Aogi, Tomoyuki Aruga, Kenichiro Inoue, Akihiko Shimomura, Eriko Tokunaga, Norikazu Masuda, Hideko Yamauchi, Toshinari Yamashita, Hiroji Iwata
Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period
Ciara C. O’Sullivan, Sheeba Irshad, Zheyu Wang, Zhuojun Tang, Christopher Umbricht, Gary L. Rosner, Mindy S. Christianson, Vered Stearns, Karen Lisa Smith
Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy
Theodore S. Jennaro, Fang Fang, Kelley M. Kidwell, Ellen M. Lavoie Smith, Kiran Vangipuram, Monika L. Burness, Jennifer J. Griggs, Catherine Van Poznak, Daniel F. Hayes, N. Lynn Henry, Daniel L. Hertz
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
Hiroshi Ishiguro, Norikazu Masuda, Nobuaki Sato, Kenji Higaki, Takashi Morimoto, Yasuhiro Yanagita, Makiko Mizutani, Shoichiro Ohtani, Koji Kaneko, Tomomi Fujisawa, Masato Takahashi, Takayuki Kadoya, Nobuki Matsunami, Yutaka Yamamoto, Shinji Ohno, Toshimi Takano, Satoshi Morita, Sachiko Tanaka-Mizuno, Masakazu Toi
De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
J. M. Simons, L. B. Koppert, E. J. T. Luiten, C. C. van der Pol, S. Samiei, J. H. W. de Wilt, S. Siesling, M. L. Smidt
Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers
S. P. Corona, M. Bortul, S. Scomersi, C. Bigal, C. Bottin, F. Zanconati, S. B. Fox, F. Giudici, D. Generali
The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women’s Health Initiative
Rachel Yung, Roberta M. Ray, Joshua Roth, Lisa Johnson, Greg Warnick, Garnet L. Anderson, Candyce H. Kroenke, Rowan T. Chlebowski, Michael S. Simon, Chunkit Fung, Kathy Pan, Di Wang, Wendy E. Barrington, Kerryn W. Reding
The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer
Lili Chen, Fangmeng Fu, Meng Huang, Jinxing Lv, Wenzhe Zhang, Chuan Wang
Trajectory of recurrent falls in post-menopausal breast cancer survivors and in matched cancer-free controls
Kathy Pan, Roberta M. Ray, Jane A. Cauley, Aladdin H. Shadyab, Arti Hurria, Rowan T. Chlebowski
Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases
Laurence Lambert-Côté, Anne-Déborah Bouhnik, Marc-Karim Bendiane, Cyril Bérenger, Myrto Mondor, Laetitia Huiart, Sophie Lauzier
A cumulative index of exposure to endogenous estrogens and breast cancer by molecular subtypes in northern Mexican women
Elodia Rojas-Lima, Brenda Gamboa-Loira, Mariano E. Cebrián, Stephen J. Rothenberg, Lizbeth López-Carrillo
Does persistent use of radiation in women > 70 years of age with early-stage breast cancer reflect tailored patient-centered care?
Lauren J. Taylor, Jennifer S. Steiman, Bethany Anderson, Jessica R. Schumacher, Lee G. Wilke, Caprice C. Greenberg, Heather B. Neuman
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
Valerie E. Crolley, Husam Marashi, Shabbir Rawther, Bhawna Sirohi, Marina Parton, Janine Graham, Anup Vinayan, Stephanie Sutherland, Anne Rigg, Anshu Wadhawan, Catherine Harper-Wynne, Emma Spurrell, Hannah Bond, Fharat Raja, Judy King
Outcomes of primary endocrine therapy in elderly women with stage I–III breast cancer: a SEER database analysis
Cai Yuan, Zhigang Xie, Jiang Bian, Jinhai Huo, Karen Daily
HER2-positivity in mucinous cancer might be related to accompanying infiltrating ductal carcinoma histology
Kadri Altundag
Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer
Ge Ma, Bin Zhang, Jin Xu
Uterine ultrasound and endometrial biopsy in tamoxifen users
P. Neven, W. Froyman, S. Timmerman, D. Timmerman